Clinical trial
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are…
NCT00114231 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00114231 |
|---|---|
| Title | Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer |
| Official title | A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | capecitabine, oxaliplatin, neoadjuvant therapy, radiation therapy |
| Enrollment | 90 |
| Start date | May 1, 2006 |
| Primary completion | Dec 1, 2013 |
| Completion | Dec 1, 2014 |
| First posted | Jun 14, 2005 |
| Last update posted | Mar 29, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: